Home > > Europe And Global Osteoarthritis Therapeutics Market- Size, Share, Growth Rate, and Forecast
TABLE OF CONTENTS CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET 3.1. OVERVIEW 3.2. EUROPE 3.2.1. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.2. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.3. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 3.2.4.1. GERMANY 3.2.4.1.1. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.1.2. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.1.3. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.2. UK 3.2.4.2.1. UK OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.2.2. UK OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.2.3. UK OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.3. FRANCE 3.2.4.3.1. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.3.2. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.3.3. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.4. ITALY 3.2.4.4.1. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.4.2. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.4.3. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.5. SPAIN 3.2.4.5.1. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.5.2. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.5.3. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.6. ROE 3.2.4.6.1. ROE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.6.2. ROE OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.6.3. ROE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION CHAPTER 4: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 4.1. OVERVIEW 4.2. KNEE OSTEOARTHRITIS 4.2.1. KNEE OSTEOARTHRITIS MARKET, BY REGION 4.2.1.1. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.2. EUROPE KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.3. ASIA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.3. HIP OSTEOARTHRITIS 4.3.1. HIP OSTEOARTHRITIS MARKET, BY REGION 4.3.1.1. NORTH AMERICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.2. EUROPE HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.3. ASIA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.4. HAND OSTEOARTHRITIS 4.4.1. HAND OSTEOARTHRITIS MARKET, BY REGION 4.4.1.1. NORTH AMERICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.2. EUROPE HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.3. ASIA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.5. SMALL JOINT OSTEOARTHRITIS 4.5.1. SMALL JOINT OSTEOARTHRITIS MARKET, BY REGION 4.5.1.1. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.2. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.3. ASIA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY CHAPTER 5: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 5.1. OVERVIEW 5.2. VISCOSUPPLEMENTATION AGENTS 5.2.1. VISCOSUPPLEMENTATION AGENTS MARKET, BY REGION 5.2.1.1. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.2. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.3. ASIA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.3. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 5.3.1. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY REGION 5.3.1.1. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.2. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.3. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.4. ANALGESICS 5.4.1. ANALGESICS MARKET, BY REGION 5.4.1.1. NORTH AMERICA ANALGESICS MARKET, BY COUNTRY 5.4.1.2. EUROPE ANALGESICS MARKET, BY COUNTRY 5.4.1.3. ASIA ANALGESICS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA ANALGESICS MARKET, BY COUNTRY 5.5. CORTICOSTEROIDS 5.5.1. CORTICOSTEROIDS MARKET, BY REGION 5.5.1.1. NORTH AMERICA CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.2. EUROPE CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.3. ASIA CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.4. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET, BY COUNTRY CHAPTER 6: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.1. OVERVIEW 6.2. PARENTERAL ROUTE 6.2.1. PARENTERAL ROUTE MARKET, BY REGION 6.2.1.1. NORTH AMERICA PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.2. EUROPE PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.3. ASIA PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET, BY COUNTRY 6.3. ORAL ROUTE 6.3.1. ORAL ROUTE MARKET, BY REGION 6.3.1.1. NORTH AMERICA ORAL ROUTE MARKET, BY COUNTRY 6.3.1.2. EUROPE ORAL ROUTE MARKET, BY COUNTRY 6.3.1.3. ASIA ORAL ROUTE MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA ORAL ROUTE MARKET, BY COUNTRY 6.4. TOPICAL ROUTE 6.4.1. TOPICAL ROUTE MARKET, BY REGION 6.4.1.1. NORTH AMERICA TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.2. EUROPE TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.3. ASIA TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET, BY COUNTRY TABLE 85. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF TABLES TABLE 01. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 02. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 03. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 04. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($MILLION) TABLE 07. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($MILLION) TABLE 08. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) TABLE 09. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 11. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 12. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 13. UK OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 14. UK OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 15. UK OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 16. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 17. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 18. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 19. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 20. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 21. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 22. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 23. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 24. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 25. ROE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 26. ROE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 27. ROE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 28. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 29. KNEE OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 30. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. EUROPE KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. ASIA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 33. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. HIP OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 35. NORTH AMERICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. EUROPE HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. ASIA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. HAND OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 40. NORTH AMERICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. EUROPE HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. ASIA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 45. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. ASIA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 49. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 50. VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 51. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. ASIA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 54. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 56. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 59. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. ANALGESICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 61. NORTH AMERICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. EUROPE ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. ASIA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 64. MIDDLE EAST & AFRICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 65. CORTICOSTEROIDS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 66. NORTH AMERICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 67. EUROPE CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 68. ASIA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 69. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 70. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 71. PARENTERAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 72. NORTH AMERICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 73. EUROPE PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 74. ASIA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 75. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 76. ORAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 77. NORTH AMERICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 78. EUROPE ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 79. ASIA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 80. MIDDLE EAST & AFRICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 81. TOPICAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 82. NORTH AMERICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 83. EUROPE TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 84. ASIA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 85. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)LIST OF FIGURES CHAPTER 1: RESEARCH METHODOLOGY 1.1. Delivery Model 1.2. Hypothesis Creation 1.3. Revenue narrow down of Companies and in-depth interviews 1.4. Data Triangulation and Validation 1.5. About Us 1.6. Key market segments CHAPTER 2: PREMIUM INSIGHTS CHAPTER 3: EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET 3.1. OVERVIEW 3.2. EUROPE 3.2.1. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.2. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.3. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY 3.2.4.1. GERMANY 3.2.4.1.1. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.1.2. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.1.3. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.2. UK 3.2.4.2.1. UK OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.2.2. UK OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.2.3. UK OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.3. FRANCE 3.2.4.3.1. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.3.2. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.3.3. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.4. ITALY 3.2.4.4.1. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.4.2. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.4.3. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.5. SPAIN 3.2.4.5.1. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.5.2. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.5.3. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 3.2.4.6. ROE 3.2.4.6.1. ROE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 3.2.4.6.2. ROE OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 3.2.4.6.3. ROE OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION CHAPTER 4: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY 4.1. OVERVIEW 4.2. KNEE OSTEOARTHRITIS 4.2.1. KNEE OSTEOARTHRITIS MARKET, BY REGION 4.2.1.1. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.2. EUROPE KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.3. ASIA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.2.1.4. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET, BY COUNTRY 4.3. HIP OSTEOARTHRITIS 4.3.1. HIP OSTEOARTHRITIS MARKET, BY REGION 4.3.1.1. NORTH AMERICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.2. EUROPE HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.3. ASIA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.3.1.4. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET, BY COUNTRY 4.4. HAND OSTEOARTHRITIS 4.4.1. HAND OSTEOARTHRITIS MARKET, BY REGION 4.4.1.1. NORTH AMERICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.2. EUROPE HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.3. ASIA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.4.1.4. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET, BY COUNTRY 4.5. SMALL JOINT OSTEOARTHRITIS 4.5.1. SMALL JOINT OSTEOARTHRITIS MARKET, BY REGION 4.5.1.1. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.2. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.3. ASIA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY 4.5.1.4. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET, BY COUNTRY CHAPTER 5: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE 5.1. OVERVIEW 5.2. VISCOSUPPLEMENTATION AGENTS 5.2.1. VISCOSUPPLEMENTATION AGENTS MARKET, BY REGION 5.2.1.1. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.2. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.3. ASIA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.2.1.4. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET, BY COUNTRY 5.3. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 5.3.1. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY REGION 5.3.1.1. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.2. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.3. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.3.1.4. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET, BY COUNTRY 5.4. ANALGESICS 5.4.1. ANALGESICS MARKET, BY REGION 5.4.1.1. NORTH AMERICA ANALGESICS MARKET, BY COUNTRY 5.4.1.2. EUROPE ANALGESICS MARKET, BY COUNTRY 5.4.1.3. ASIA ANALGESICS MARKET, BY COUNTRY 5.4.1.4. MIDDLE EAST & AFRICA ANALGESICS MARKET, BY COUNTRY 5.5. CORTICOSTEROIDS 5.5.1. CORTICOSTEROIDS MARKET, BY REGION 5.5.1.1. NORTH AMERICA CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.2. EUROPE CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.3. ASIA CORTICOSTEROIDS MARKET, BY COUNTRY 5.5.1.4. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET, BY COUNTRY CHAPTER 6: GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION 6.1. OVERVIEW 6.2. PARENTERAL ROUTE 6.2.1. PARENTERAL ROUTE MARKET, BY REGION 6.2.1.1. NORTH AMERICA PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.2. EUROPE PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.3. ASIA PARENTERAL ROUTE MARKET, BY COUNTRY 6.2.1.4. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET, BY COUNTRY 6.3. ORAL ROUTE 6.3.1. ORAL ROUTE MARKET, BY REGION 6.3.1.1. NORTH AMERICA ORAL ROUTE MARKET, BY COUNTRY 6.3.1.2. EUROPE ORAL ROUTE MARKET, BY COUNTRY 6.3.1.3. ASIA ORAL ROUTE MARKET, BY COUNTRY 6.3.1.4. MIDDLE EAST & AFRICA ORAL ROUTE MARKET, BY COUNTRY 6.4. TOPICAL ROUTE 6.4.1. TOPICAL ROUTE MARKET, BY REGION 6.4.1.1. NORTH AMERICA TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.2. EUROPE TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.3. ASIA TOPICAL ROUTE MARKET, BY COUNTRY 6.4.1.4. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET, BY COUNTRY TABLE 01. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 02. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 03. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 04. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 05. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY REGION, 2023-2030, ($MILLION) TABLE 06. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($MILLION) TABLE 07. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($MILLION) TABLE 08. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($MILLION) TABLE 09. EUROPE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 10. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 11. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 12. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 13. UK OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 14. UK OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 15. UK OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 16. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 17. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 18. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 19. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 20. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 21. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 22. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 23. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 24. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 25. ROE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 26. ROE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 27. ROE OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 28. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ANATOMY, 2023-2030, ($ MILLION) TABLE 29. KNEE OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 30. NORTH AMERICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 31. EUROPE KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 32. ASIA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 33. MIDDLE EAST & AFRICA KNEE OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 34. HIP OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 35. NORTH AMERICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 36. EUROPE HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 37. ASIA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 38. MIDDLE EAST & AFRICA HIP OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 39. HAND OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 40. NORTH AMERICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 41. EUROPE HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 42. ASIA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 43. MIDDLE EAST & AFRICA HAND OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 44. SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 45. NORTH AMERICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 46. EUROPE SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 47. ASIA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 48. MIDDLE EAST & AFRICA SMALL JOINT OSTEOARTHRITIS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 49. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY DRUG TYPE, 2023-2030, ($ MILLION) TABLE 50. VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 51. NORTH AMERICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 52. EUROPE VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 53. ASIA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 54. MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION AGENTS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 55. NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 56. NORTH AMERICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 57. EUROPE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 58. ASIA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 59. MIDDLE EAST & AFRICA NONSTEROIDAL ANTI-INFLAMMATORY DRUGS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 60. ANALGESICS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 61. NORTH AMERICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 62. EUROPE ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 63. ASIA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 64. MIDDLE EAST & AFRICA ANALGESICS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 65. CORTICOSTEROIDS MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 66. NORTH AMERICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 67. EUROPE CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 68. ASIA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 69. MIDDLE EAST & AFRICA CORTICOSTEROIDS MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 70. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET VALUE, BY ROUTE OF ADMINISTRATION, 2023-2030, ($ MILLION) TABLE 71. PARENTERAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 72. NORTH AMERICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 73. EUROPE PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 74. ASIA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 75. MIDDLE EAST & AFRICA PARENTERAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 76. ORAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 77. NORTH AMERICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 78. EUROPE ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 79. ASIA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 80. MIDDLE EAST & AFRICA ORAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 81. TOPICAL ROUTE MARKET VALUE, BY REGION, 2023-2030, ($ MILLION) TABLE 82. NORTH AMERICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 83. EUROPE TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 84. ASIA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION) TABLE 85. MIDDLE EAST & AFRICA TOPICAL ROUTE MARKET VALUE, BY COUNTRY, 2023-2030, ($MILLION)